2
R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation
more
Stories about Medikament
The New Era Biotechnology Co., Ltd.
The New Era Biotechnology deepens cooperation between China and Belarus in the Great Stone China Belarus Industrial Park (CBIP)
moreAlmirall delivers solid nine months 2021 results and tightens its upgraded guidance
Barcelona, Spain (ots/PRNewswire) - - Strong Core business performance with growth in Core Net Sales EUR601.7 MM (+6.2% year-on-year) and Core EBITDA reaching EUR164.2 MM, (+20.3% year-on-year) driven by positive contribution from Growth Drivers and a strong EU dermatology performance - Key Growth Drivers underpinning increase in Core Net Sales. Strong performance from ...
moreCPhI worldwide: German probiotics company SYNformulas seeks partnerships to drive internationalization
moreShockwave therapy brings new healing opportunities for heart attack patients and hope for people with spinal cord injuries
Vienna (ots) - Success Story of Extracorporeal Shock Wave Therapy (ESWT) Successful for over 40 years in urology for the disintegration of kidney stones, with high efficiency and hardly any side effects worth mentioning. How does the shock wave work? Without causing mechanical damage, shockwaves trigger a biological ...
moreDr. Dirk Winnemöller joins Leukocare as Vice President Commercial
Martinsried/Munich (ots) - Leukocare AG, a biotechnology company specialized in the field of biopharmaceutical formulation development, today announced that Dr. Dirk Winnemöller took up the newly established role as Vice President Commercial at Leukocare. Dirk joins the Company from Miltenyi Biomedicine GmbH, Bergisch Gladbach, Germany, where he served as Global Vice ...
more
Technische Universität München
New X-ray technology: Dark-field X-ray technology improves diagnosis of pulmonary ailments
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/36892 High resolution images: https://mediatum.ub.tum.de/1621886 NEWS RELEASE New X-ray technology first used with patients Dark-field X-ray technology ...
moreCPhI worldwide: German probiotics company SYNformulas seeks partnerships to drive internationalization
Press release Combating intestinal complaints and allergies CPhI worldwide: German probiotics company SYNformulas seeks partnerships to drive internationalization - SYNformulas, leading probiotics supplier from Germany, will exhibit for the first time at the pharmaceutical trade fair CPhI worldwide in Milan - Focus ...
moreAlmirall S.A.: Experts highlight the need to focus on psoriasis patients' wellbeing in clinical practice
Barcelona, Spain (ots/PRNewswire) - - Psoriasis affects the overall emotional wellbeing of 88% of patients[1], and at least 20% of psoriasis patients have considered suicide[2] - Currently used endpoints in psoriasis do not capture the full impact of this skin condition on patients' lives, and almost 50% of them ...
moreTechnische Universität München
A protein causes higher risk of severe cancer progression for men
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/36939 High resolution images: https://mediatum.ub.tum.de/1631416 NEWS RELEASE Cause found for higher sex-specific risk of mortality A protein causes significantly higher risk of severe cancer progression for men A ...
moreTechnische Universität München
The proteins of Covid-19: machine learning assisted structure analysis reveals SARS-CoV-2 virus tactics
TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/36913 High resolution images: https://mediatum.ub.tum.de/1624573 NEWS RELEASE The proteins of Covid-19 ...
moreEleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H
Freiburg (ots) - Eleva, a manufacturer of superior biologics, is scaling up its production capacity to 2500 l in state-of-the-art single-use reactors. This will produce enough factor H to cover all three clinical phases. Eleva has ordered four more state-of-the-art, 500 l single-use reactors from Sartorius Stedim Systems. The scale-up will enable Eleva to enter ...
more
Technische Universität München
Messengers from gut to brain
TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/36901 High resolution images: https://mediatum.ub.tum.de/1622134 NEWS RELEASE Messengers from gut to brain Seen for the first time: T cells traveling from the gut and skin to the central nervous system Scientists have long been aware of a link between the gut ...
moreGold Standard Diagnostics Europe
Novatec and Virotech to become Gold Standard Diagnostics Europe
Dietzenbach (ots) - The two German diagnostics companies Novatec Immundiagnostica GmbH and Virotech Diagnostics GmbH are excited to announce that they have joined forces and will now operate together as Gold Standard Diagnostics Europe. Both entities have agreed to consolidate their businesses to better address their partners´ needs and demands. Since the SARS COV 2 outbreak, the companies have been committed to ...
more- 6
Press Release MAHLE Covid-19 worldwide vaccination initiatives
more Lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic deramatitis in two Phase 3 trials
Barcelona (ots/PRNewswire) - - Primary and all key secondary endpoints including itch, interference of itch on sleep and quality of life were met at Week 16 in two pivotal Phase 3 trials - Safety profile consistent with prior lebrikizumab studies in atopic dermatitis Lebrikizumab led to significant improvements with ...
moreePresentation of the results of the in-vitro study regarding the anti-proliferative and pro-apoptotic effects of Polyphenon® E (Veregen®) at the 31st German Skin Cancer Congress on 10 September 2021
Strausberg (ots) - Aresus Pharma GmbH, a company of DERMAGO Holding GmbH, announced today that the abstract "Inhibition of cell-proliferation and cell viability by Polyphenon E ® (Veregen®) in cutaneous SCC cell lines" has been accepted as an e-poster short presentation at the 31st German Skin Cancer Congress. In ...
moreTechnische Universität München
The virus trap: hollow nano-objects made of DNA could trap viruses and render them harmless
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36810/ High resolution images: https://mediatum.ub.tum.de/1616943 NEWS RELEASE The virus trap Hollow ...
more
ZOE Study Reveals Eating a Plant Rich Diet Reduces Risk of Developing COVID-19 and Going to the Hospital
more
2Tianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM
more
Tianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM
more- 3
Vascudyne Announces Successful First Human Use of TRUE Vascular Graft for Hemodialysis Access
more Technische Universität München
Versatile, fast and reliable: new automated microarray rapid test detects SARS-CoV-2 antibodies
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36762/ High resolution images: https://mediatum.ub.tum.de/1615381 NEWS RELEASE Versatile, fast and reliable SARS-CoV-2 antibody assay Automated microarray ...
moreTechnische Universität München
Animal health through genomics | Feasibility study: Preventing diseases through genome analysis and genome scissors
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36757/ High resolution images: https://mediatum.ub.tum.de/1615373 Animal health through genomics Feasibility study: Preventing diseases ...
more
Technische Universität München
In many cases, MS starts long before the diagnosis
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36707/ Picture: https://mediatum.ub.tum.de/1615270 NEWS RELEASE In many cases, MS starts long before the diagnosis Multiple sclerosis is often diagnosed years after the first symptoms appear Years before they ...
moreAM plays to its strengths in the medical field
One documentmoreEuropean Inventor Award 2021: Meet some of today’s most inspiring innovators at digital event on 17 June
moreInvestment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15M
moreTechnische Universität München
New AI technology protects privacy in medical diagnostics
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36689/ Highresolution pictures: https://mediatum.ub.tum.de/1612604 NEWS RELEASE New AI technology protects privacy Medical diagnostics algorithm identifies pneumonia in paediatric x-ray images AI algorithms can ...
moreDid my vaccine work? New rapid test for the determination of vaccination success
more
Previous1234567Next